Top Markets
Coin of the day
Apollomics, Inc. Apollomics, Inc.

Apollomics, Inc.

APLM
Rang in aandelen #25243
Apollomics, Inc., a biotechnology enterprise established in 2015 and... Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.
Aandeelprijs
$23.57
Laatst gesynchroniseerd: 2026-08-20
Marktkapitalisatie
$51.76M
Verandering (1 dag)
-0.08%
Verandering (1 jaar)
289.59%
Land
US
Handel Apollomics, Inc. (APLM)

Categorie

Koersgeschiedenis voor Apollomics, Inc. (APLM)
Hoogste slotkoers: $20.22 op 2026-08-01

Laagste slotkoers: $990.67 op 2021-11-01
Koersgeschiedenis van Apollomics, Inc. van 2021 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 0.80%
2025 83.86%
2024 -88.89%
2023 -91.94%
2022 3.60%
2021 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.70 -18.24%
AU
$761.87 8.65%
CH
$130.43 397.46%
US